ADEONA PHARMACEUTICALS INC SCHEDULE 13D 12-7-2011

Company

Theriva Biologics, Inc.

Filed

December 12, 2011

Accession Number

0001140361-11-057083

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →